| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |